Biomarkers and neurobehavioral diagnosis
Biomarkers in Neuropsychiatry · 2021-06 · 4 · 100029
DOI: 10.1016/j.bionps.2020.100029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomarkers in Neuropsychiatry, 2021-06. Verfasst von Joshua B Ewen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Kennedy Krieger Institute. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, NIMH NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Our current diagnostic methods for treatment planning in Psychiatry and Neurodevelopmental Disabilities leave room for improvement, and null results in clinical trials in these fields may be a result of insufficient tools for patient stratification. Great hope has been placed in novel technologies to improve clinical and trial outcomes, but we have yet to see a substantial change in clinical practice. As we examine attempts at biomarker validation within these fields, we find that it may be the diagnoses themselves that fall short. We now need to improve neuropsychiatric nosologies with a focus on validity based not solely on behavioral features, but on a synthesis that includes genetic and biological data as well. The eventual goal is diagnostic biomarkers and diagnoses themselves based on distinct mechanisms, but such an understanding of the causal relationship across levels of analysis is likely to be elusive for some time. Rather, we propose an approach in the near-term that deconstructs diagnosis into a series of independent, empiric and clinically relevant associations among a single, defined patient group, a single biomarker, a single intervention and a single clinical outcome. Incremental study across patient groups, interventions, outcomes and modalities will lead to a more interdigitated network of knowledge, and correlations in metrics across levels of analysis will eventually give way to the causal understanding that will allow for mechanistically based diagnoses.
Autor:innen und Institutionen
- Kennedy Krieger Institute.
- Johns Hopkins University.
- The National Institutes of Health.
- University of Cincinnati.
Förderung
- NICHD NIH HHS
- NIMH NIH HHS
- National Institutes of Health
- National Natural Science Foundation of China
Zitieren
APA
Ewen, J. B., Potter, W. Z., & Sweeney, J. A. (2021). Biomarkers and neurobehavioral diagnosis. Biomarkers in Neuropsychiatry, 4, 100029. https://doi.org/10.1016/j.bionps.2020.100029
Vancouver
Ewen JB, Potter WZ, Sweeney JA. Biomarkers and neurobehavioral diagnosis. Biomarkers in Neuropsychiatry. 2021;4:100029. doi:10.1016/j.bionps.2020.100029
BibTeX
@article{Ewen2021,
author = {Ewen, Joshua B and Potter, William Z and Sweeney, John A},
title = {Biomarkers and neurobehavioral diagnosis},
journal = {Biomarkers in Neuropsychiatry},
year = {2021},
volume = {4},
pages = {100029},
doi = {10.1016/j.bionps.2020.100029}
}
EUVIMED